Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons

被引:62
作者
Chalmers, Katy A. [1 ]
Love, Seth [1 ]
机构
[1] Univ Bristol, N Bristol Frenchay Hosp, Inst Clin Neurosci, Dept Clin Sci,Dementia Res Grp, Bristol BS8 1TH, Avon, England
关键词
Alzheimer disease; neurofibrillary tangles; Smad signaling; transforming growth factor beta (TGF beta);
D O I
10.1097/nen.0b013e3180303b93
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Transforming growth factor (TGF)-beta is a multifunctional cytokine with anti-inflammatory, reparative and neuroprotective functions. Increased levels of TGF beta in Alzheimer disease (AD) are associated with perivascular deposition of extracellular matrix, which may impair clearance of beta-amyloid and contribute to the development of cerebral amyloid angiopathy. TGF beta signaling is transduced by Smad proteins: on TGF beta receptor activation, Smads 2 and 3 are released from sequestration by microtubules, phosphorylated (forming pSmad2/3), and, together with Smad 4, translocated to the nucleus, where they initiate the transcription of multiple genes. Neuronal microtubule assembly is disturbed in AD when tau, a microtubule-stabilizing protein, is hyperphosphorylated and forms neurofibrillary tangles. We have investigated the relationship between Ser202 phospho-tau and pSmads 2 and 3 in the temporal lobe in AD. Within neurons in control brains, pSmads 2 and 3 were almost exclusively intranuclear. In AD, pSmad 3 bound to phospho-tau (mostly insoluble tau) and accumulated in the cytoplasm of tangle-bearing neurons; this was accompanied by a marked decrease in nuclear pSmad3. pSmads 2 and 3 were also present in neuronal gramilovacuolar inclusions. Our findings suggest that neurofibrillary tangles sequester pSmad3, preventing its translocation into the nucleus and the induction of gene transcription. Interference with the Smad signaling may adversely affect survival of tangle-bearing neurons in AD.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 39 条
[1]   Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease [J].
Baig, S ;
Wilcock, GK ;
Love, S .
ACTA NEUROPATHOLOGICA, 2005, 110 (04) :393-401
[2]  
BONDAREFF W, 1991, AM J PATHOL, V139, P641
[3]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[4]   Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease [J].
Brückner, G ;
Hausen, D ;
Härtig, W ;
Drlicek, M ;
Arendt, T ;
Brauer, K .
NEUROSCIENCE, 1999, 92 (03) :791-805
[5]  
Chalmers K, 2006, BRAIN PATHOL, V16, pS159
[6]   TRANSFORMING GROWTH-FACTOR-BETA IN ALZHEIMERS-DISEASE [J].
CHAO, CC ;
HU, SX ;
FREY, WH ;
ALA, TA ;
TOURTELLOTTE, WW ;
PETERSON, PK .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (01) :109-110
[7]   Smads:: Transcriptional activators of TGF-β responses [J].
Derynck, R ;
Zhang, Y ;
Feng, XH .
CELL, 1998, 95 (06) :737-740
[8]  
DICKSON DW, 1993, ACTA NEUROPATHOL, V85, P463
[9]   Microtubule binding to Smads may regulate TGFβ activity [J].
Dong, CM ;
Li, ZR ;
Alvarez, R ;
Feng, XH ;
Goldschmidt-Clermont, PJ .
MOLECULAR CELL, 2000, 5 (01) :27-34
[10]   ALTERED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA IN ALZHEIMERS-DISEASE [J].
FLANDERS, KC ;
LIPPA, CF ;
SMITH, TW ;
POLLEN, DA ;
SPORN, MB .
NEUROLOGY, 1995, 45 (08) :1561-1569